Cargando…
Comorbidities and Antithrombotic Treatment Pattern in Patients With Atrial Fibrillation
OBJECTIVE: Non-vitamin K antagonist oral anticoagulants (NOACs) are proven alternatives to warfarin for preventing stroke in patients with non-valvular atrial fibrillation. We aimed to examine the treatment patterns and patient factors associated with the use of antiplatelet agents, warfarin, and NO...
Autores principales: | Bang, Oh Young, Kim, Siin, On, Young Keun, Lee, Myung-Yong, Jang, Sung-Won, Han, Seongwook, Ryu, Jaeyun, Kang, Seongsik, Suh, Hae Sun, Kim, Young-Hoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931391/ https://www.ncbi.nlm.nih.gov/pubmed/35309578 http://dx.doi.org/10.3389/fneur.2022.761603 |
Ejemplares similares
-
Treatment Pattern of Antithrombotic Therapy over Time after Percutaneous Coronary Intervention in Patients with Atrial Fibrillation in Real-World Practice in Korea
por: Han, Seongwook, et al.
Publicado: (2021) -
Impact of Reduced-Dose Nonvitamin K Antagonist Oral Anticoagulants on Outcomes Compared to Warfarin in Korean Patients with Atrial Fibrillation: A Nationwide Population-Based Study
por: Han, Sola, et al.
Publicado: (2021) -
Effectiveness and safety of non‐vitamin K antagonist oral anticoagulants in patients with non‐valvular atrial fibrillation: A nationwide, population‐based study in Korea
por: Han, Seongwook, et al.
Publicado: (2021) -
The risk of stroke/systemic embolism and major bleeding in Asian patients with non-valvular atrial fibrillation treated with non-vitamin K oral anticoagulants compared to warfarin: Results from a real-world data analysis
por: Bang, Oh Young, et al.
Publicado: (2020) -
Atrial Fibrillation Related and Unrelated Stroke Recurrence Among Ischemic Stroke Patients With Atrial Fibrillation
por: Kim, Bum Joon, et al.
Publicado: (2021)